Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: Effect of niacin monotherapy on high density lipoprotein composition and function

Fig. 1

Study design. Schematic of the time course of the study. After qualifying for the study, eligible participants had a baseline visit followed by a two-week run in period where extended-release niacin was escalated to the target dose of 2000 mg/day. Tolerance was evaluated after week 2. Target dose was maintained until week 16 followed by a 4 week washout period. Research blood collected at baseline, week 16, and week 20 was used for lipoprotein proteome and functional assays

Back to article page